title: DNA methylation profiles of primary colorectal carcinoma and matched liver metastasis.
abstract: BACKGROUND
  The contribution of DNA methylation to the metastatic process in colorectal cancers (CRCs) is unclear.
  
  
  METHODS
  We evaluated the methylation status of 13 genes (MINT1, MINT2, MINT31, MLH1, p16, p14, TIMP3, CDH1, CDH13, THBS1, MGMT, HPP1 and ERα) by bisulfite-pyrosequencing in 79 CRCs comprising 36 CRCs without liver metastasis and 43 CRCs with liver metastasis, including 16 paired primary CRCs and liver metastasis. We also performed methylated CpG island amplification microarrays (MCAM) in three paired primary and metastatic cancers.
  
  
  RESULTS
  Methylation of p14, TIMP3 and HPP1 in primary CRCs progressively decreased from absence to presence of liver metastasis (13.1% vs. 4.3%; 14.8% vs. 3.7%; 43.9% vs. 35.8%, respectively) (P<.05). When paired primary and metastatic tumors were compared, only MGMT methylation was significantly higher in metastatic cancers (27.4% vs. 13.4%, P = .013), and this difference was due to an increase in methylation density rather than frequency in the majority of cases. MCAM showed an average 7.4% increase in DNA methylated genes in the metastatic samples. The numbers of differentially hypermethylated genes in the liver metastases increased with increasing time between resection of the primary and resection of the liver metastasis. Bisulfite-pyrosequencing validation in 12 paired samples showed that most of these increases were not conserved, and could be explained by differences in methylation density rather than frequency.
  
  
  CONCLUSIONS
  Most DNA methylation differences between primary CRCs and matched liver metastasis are due to random variation and an increase in DNA methylation density rather than de-novo inactivation and silencing. Thus, DNA methylation changes occur for the most part before progression to liver metastasis.
authors: Department of Leukemia, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America. konishimd@med.showa-u.ac.jp
authors: Kazuo
authors: K
authors: Konishi
authors: Yoshiyuki
authors: Y
authors: Watanabe
authors: Lanlan
authors: L
authors: Shen
authors: Yi
authors: Y
authors: Guo
authors: Ryan J
authors: RJ
authors: Castoro
authors: Kimie
authors: K
authors: Kondo
authors: Woonbok
authors: W
authors: Chung
authors: Saira
authors: S
authors: Ahmed
authors: Jaroslav
authors: J
authors: Jelinek
authors: Yanis A
authors: YA
authors: Boumber
authors: Marcos R
authors: MR
authors: Estecio
authors: Shinji
authors: S
authors: Maegawa
authors: Yutaka
authors: Y
authors: Kondo
authors: Fumio
authors: F
authors: Itoh
authors: Michio
authors: M
authors: Imawari
authors: Stanley R
authors: SR
authors: Hamilton
authors: Jean-Pierre J
authors: JP
authors: Issa
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D045744:Cell Line, Tumor; D015179:Colorectal Neoplasms / Q000235:genetics*; D018899:CpG Islands / Q000235:genetics; D019175:DNA Methylation / Q000235:genetics*; D004252:DNA Mutational Analysis; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D015894:Genome, Human / Q000235:genetics; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics* / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D020411:Oligonucleotide Array Sequence Analysis